Harvard researchers call for a discussion and development of guidelines for 'embryoid' research, NPR reports.
In Science this week: a suite of studies from the Synthetic Yeast genome Project.
The worldwide distribution agreement expands Oxford's existing product and service portfolio, streamlining workflows for current customers, the company said.
The UN Convention on Biodiversity has rejected a moratorium on gene drives, Nature News says.
The company is hoping to find a niche among customers who want the quality of high-throughput oligonucleotide synthesis but smaller order volumes.
The President's Council of Advisors on Science and Technology urges the adoption of a biodefense strategy, Tech Review reports.
The company said it would use the funding to continue licensing its DNA design technology in the cell and gene therapy markets.
The DNA foundries have been funded through an £18 million ($23.5 million) investment from the BBSRC and should all be fully operational by next year.
In Science this week: effort to reduce E. coli genome, and more.
The Scientist traces the career path of the J. Craig Venter Institute's Clyde Hutchinson.
Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.
US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.
Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.
In Science this week: almond reference genome, and more.